National Advisory Unit on Late Effects After Cancer Treatment, Oslo University Hospital, Department of Clinical Cancer Research, Norway.
Department of Radiology and Nuclear Medicine, Division of Diagnostics and Intervention, Oslo University Hospital, Norway.
Radiother Oncol. 2015 Mar;114(3):328-34. doi: 10.1016/j.radonc.2015.01.006. Epub 2015 Jan 16.
BACKGROUND/PURPOSE: We explored the relation between coronary artery calcium (CAC) and cardiac radiation doses in breast cancer survivors (BCS) treated with radiotherapy (RT). Additionally, we examined the impact of other risk factors and biomarkers of coronary artery disease (CAD).
236 BCS (median age 51years [range 30-70], median observation time 12years [9.2-15.7]), treated with 4-field RT of 50GY, were included and examined in 2004 (T1), 2007 (T2) and 2011 (T3) with clinical examination, blood tests and questionnaires. At T3, cardiac computed tomography was performed with quantification of CAC using Agatston score (AS). For 106 patients cardiac dose volume histograms were available.
The cohort-based median of the mean cardiac dose was 2.5 (range 0.5-7.0) Gy. There was no correlation between measures of cardiac dose and AS. AS was correlated with high cholesterol at T1/T2 (p=0.022), high proBNP at T1/T2 (p<0.022) and T3 (p<0.022) and high HbA1c at T3 (p=0.022). In addition, a high AS was significantly associated with hypertension (p=0.022). Age (p<0.001) and cholesterol at T1/T2 (p=0.001) retained significant associations in multivariate analysis.
Traditional, modifiable risk factors of CAD correlate with CAC and may be important for the long term risk of CAD after RT. With low to moderate cardiac radiation exposure, a contribution of radiation dose to CAC could not be demonstrated.
背景/目的:我们探讨了接受放射治疗(RT)的乳腺癌幸存者(BCS)的冠状动脉钙(CAC)与心脏辐射剂量之间的关系。此外,我们还研究了其他冠心病(CAD)的危险因素和生物标志物的影响。
共纳入 236 名接受 50GY 四野 RT 治疗的 BCS(中位年龄 51 岁[范围 30-70],中位观察时间 12 年[9.2-15.7]),并于 2004 年(T1)、2007 年(T2)和 2011 年(T3)进行了临床检查、血液检查和问卷调查。在 T3 时,使用 Agatston 评分(AS)对心脏进行计算机断层扫描并对 CAC 进行量化。对于 106 例患者,可获得心脏剂量体积直方图。
基于队列的平均心脏剂量中位数为 2.5(范围 0.5-7.0)Gy。心脏剂量测量值与 AS 之间无相关性。AS 与 T1/T2 时的高胆固醇(p=0.022)、T1/T2 时和 T3 时的高 proBNP(p<0.022)以及 T3 时的高 HbA1c(p=0.022)相关。此外,高 AS 与高血压显著相关(p=0.022)。年龄(p<0.001)和 T1/T2 时的胆固醇(p=0.001)在多变量分析中仍具有显著相关性。
CAD 的传统、可改变的危险因素与 CAC 相关,可能是 RT 后 CAD 长期风险的重要因素。心脏辐射暴露低至中度时,不能证明辐射剂量对 CAC 的贡献。